190 related articles for article (PubMed ID: 16882533)
1. Nested case-control study of autoimmune disease in an asbestos-exposed population.
Noonan CW; Pfau JC; Larson TC; Spence MR
Environ Health Perspect; 2006 Aug; 114(8):1243-7. PubMed ID: 16882533
[TBL] [Abstract][Full Text] [Related]
2. Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA.
Peipins LA; Lewin M; Campolucci S; Lybarger JA; Miller A; Middleton D; Weis C; Spence M; Black B; Kapil V
Environ Health Perspect; 2003 Nov; 111(14):1753-9. PubMed ID: 14594627
[TBL] [Abstract][Full Text] [Related]
3. Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: update of a cohort mortality study.
Sullivan PA
Environ Health Perspect; 2007 Apr; 115(4):579-85. PubMed ID: 17450227
[TBL] [Abstract][Full Text] [Related]
4. Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA.
Pfau JC; Sentissi JJ; Weller G; Putnam EA
Environ Health Perspect; 2005 Jan; 113(1):25-30. PubMed ID: 15626643
[TBL] [Abstract][Full Text] [Related]
5. A review of the federal government's health activities in response to asbestos-contaminated ore found in Libby, Montana.
Horton K; Kapil V; Larson T; Muravov O; Melnikova N; Anderson B
Inhal Toxicol; 2006 Nov; 18(12):925-40. PubMed ID: 16920666
[TBL] [Abstract][Full Text] [Related]
6. Case series: rheumatological manifestations attributed to exposure to Libby Asbestiform Amphiboles.
Diegel R; Black B; Pfau JC; McNew T; Noonan C; Flores R
J Toxicol Environ Health A; 2018; 81(15):734-747. PubMed ID: 29927712
[TBL] [Abstract][Full Text] [Related]
7. Mortality from asbestos-associated disease in Libby, Montana 1979-2011.
Naik SL; Lewin M; Young R; Dearwent SM; Lee R
J Expo Sci Environ Epidemiol; 2017 Mar; 27(2):207-213. PubMed ID: 27025411
[TBL] [Abstract][Full Text] [Related]
8. Radiographic evidence of nonoccupational asbestos exposure from processing Libby vermiculite in Minneapolis, Minnesota.
Alexander BH; Raleigh KK; Johnson J; Mandel JH; Adgate JL; Ramachandran G; Messing RB; Eshenaur T; Williams A
Environ Health Perspect; 2012 Jan; 120(1):44-9. PubMed ID: 21992801
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of computed tomography in detecting asbestos-related pleural abnormalities in people who had indeterminate chest radiographs: the Libby, MT, experience.
Muravov OI; Kaye WE; Lewin M; Berkowitz Z; Lybarger JA; Campolucci SS; Parker JE
Int J Hyg Environ Health; 2005; 208(1-2):87-99. PubMed ID: 15881982
[TBL] [Abstract][Full Text] [Related]
10. Cancer incidence and mortality associated with non-occupational and low dose exposure to Libby vermiculite in Minnesota.
Konen T; Johnson JE; Lindgren P; Williams A
Environ Res; 2019 Aug; 175():449-456. PubMed ID: 31158563
[TBL] [Abstract][Full Text] [Related]
11. Libby vermiculite exposure and risk of developing asbestos-related lung and pleural diseases.
Antao VC; Larson TC; Horton DK
Curr Opin Pulm Med; 2012 Mar; 18(2):161-7. PubMed ID: 22139761
[TBL] [Abstract][Full Text] [Related]
12. Exposure to asbestos-containing vermiculite ore and respiratory symptoms among individuals who were children while the mine was active in Libby, Montana.
Vinikoor LC; Larson TC; Bateson TF; Birnbaum L
Environ Health Perspect; 2010 Jul; 118(7):1033-28. PubMed ID: 20332072
[TBL] [Abstract][Full Text] [Related]
13. Exposure matrix development for the Libby cohort.
Noonan CW
Inhal Toxicol; 2006 Nov; 18(12):963-7. PubMed ID: 16920669
[TBL] [Abstract][Full Text] [Related]
14. Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control study.
Ilar A; Klareskog L; Saevarsdottir S; Wiebert P; Askling J; Gustavsson P; Alfredsson L
RMD Open; 2019; 5(2):e000978. PubMed ID: 31413868
[TBL] [Abstract][Full Text] [Related]
15. Radiographic abnormalities and asbestos exposure: Libby, Montana.
Price B
Environ Health Perspect; 2004 Feb; 112(2):A82-3, author reply A83. PubMed ID: 14754585
[No Abstract] [Full Text] [Related]
16. Exposure to airborne amphibole structures and health risks: Libby, Montana.
Price B
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S97-S109. PubMed ID: 18006127
[TBL] [Abstract][Full Text] [Related]
17. Modeling community asbestos exposure near a vermiculite processing facility: Impact of human activities on cumulative exposure.
Adgate JL; Cho SJ; Alexander BH; Ramachandran G; Raleigh KK; Johnson J; Messing RB; Williams AL; Kelly J; Pratt GC
J Expo Sci Environ Epidemiol; 2011; 21(5):529-35. PubMed ID: 21343955
[TBL] [Abstract][Full Text] [Related]
18. Exposure pathway evaluations for sites that processed asbestos-contaminated vermiculite.
Anderson BA; Dearwent SM; Durant JT; Dyken JJ; Freed JA; Moore SM; Wheeler JS
Int J Hyg Environ Health; 2005; 208(1-2):55-65. PubMed ID: 15881979
[TBL] [Abstract][Full Text] [Related]
19. Follow-Up of the Libby, Montana Screening Cohort: A 17-Year Mortality Study.
Larson TC; Williamson L; Antao VC
J Occup Environ Med; 2020 Jan; 62(1):e1-e6. PubMed ID: 31714372
[TBL] [Abstract][Full Text] [Related]
20. Lung Cancer in an Orthoprosthetist Using Vermiculite.
Durand-Moreau Q; Dezutter M; Quéré G; Robinet G; Le Roux PY; Loddé B; Dewitte JD
Int J Occup Environ Med; 2017 Oct; 8(4):241-243. PubMed ID: 28970599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]